Navigation Links
WuXi PharmaTech Appoints Stewart Hen and Ning Zhao to Its Board of Directors; Tao Lin Leaves Board
Date:2/5/2009

SHANGHAI, China, Feb. 5 /PRNewswire-Asia/ - WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, today announced the addition of Stewart Hen and Ning Zhao to the WuXi PharmaTech Board of Directors.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

Dr. Ge Li, WuXi's Chairman and Chief Executive Officer, commented, ''We welcome the addition of Stewart Hen and Ning Zhao to the board. Each brings invaluable expertise as we work to anticipate and meet our customers' evolving needs for improving R&D productivity.''

Mr. Hen is a managing director at Warburg Pincus LLC, a leading global private equity firm. He focuses on investments in biotechnology and pharmaceuticals, including pharmaceutical outsourcing. Mr. Hen has more than 17 years of experience in the life sciences industry. Prior to Warburg Pincus, he was a consultant at McKinsey & Company serving the pharmaceutical industry. Previously, he worked at Merck in both research and development and manufacturing. Mr. Hen holds an M.B.A. from the Wharton School of the University of Pennsylvania and an M.S. in chemical engineering from the Massachusetts Institute of Technology.

Dr. Zhao, one of WuXi's co-founders, is currently lead advisor to the company's analytical services operations. She was vice president of WuXi's analytical department from 2004 to 2008 and also established its Bio-Analytical Services, Core Analytical Services, and Analytical Development Services departments. She previously worked for Wyeth as a senior research scientist, for Pharmacopeia as a group leader for the high-throughput analysis of combinatorial libraries, and for Bristol-Myers Squibb as a site leader in the Discovery Analytical Sciences department. Dr. Zhao is the co-inventor of numerous patents and has published and presented more than 36 scientific papers. With more than 10 years' experience in analytical sciences in the U.S. pharmaceutical industry, she has received numerous awards, including the 2002 Chemistry Leadership Award from Bristol-Myers Squibb and the 1995 Pegram Award from Columbia University, where she received her Ph.D. Dr. Zhao is married to Dr. Li.

Separately, WuXi announced that Mr. Tao Lin, the company's Vice President of Internal Operations since 2002 and a director of the company since 2005, has resigned from the board of directors and as a company officer for personal reasons. Mr. Lin was one of the founders of the company.

''I want to personally thank Tao for his counsel and wisdom while serving on our board,'' said Dr. Li. ''As a founder and key executive of the company, Tao made many contributions to build WuXi from a start-up to the strong company we are today. We all wish him well.''

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology, and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: http://www.wuxiapptec.com .

    For more information, please contact:

     Ronald Aldridge
     Director of Investor Relations
     WuXi PharmaTech (Cayman) Inc.
     Tel:   +1-215-218-5515
     Email: ir@wuxiapptec.com

'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. WuXi PharmaTech to Present at 20th Annual Piper Jaffray Healthcare Conference
2. WuXi PharmaTech Expands Collaboration for Fully Integrated Services
3. WuXi PharmaTech Announces Second Quarter 2008 Results
4. WuXi PharmaTech (NYSE: WX) Appoints Mr. Steven M. Hutchins as VP of Business Development
5. Dr. Richard M. Soll Joined WuXi PharmaTech (NYSE: WX) as VP of Medicinal Chemistry
6. WuXi PharmaTech 2007 Annual Report Available Online
7. The First QPatch HT in China Placed in WuXi PharmaTech (NYSE: WX)
8. Stanford Professor Barry M. Trost Visits WuXi PharmaTech and Gives Two Seminars
9. WuXi PharmaTech Announces Postponement of Proposed Follow-on Offering
10. Princeton Professor David W. C. MacMillan Lectured WuXi PharmaTech Scientists
11. WuXi PharmaTech (NYSE: WX) Names Temporary Chairman of the Audit Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... ... January 16, 2017 , ... Board-certified oculoplastic surgeon ... , the official journal of The American Society for Aesthetic Plastic Surgery, in ... procedure is designed to correct drooping, retracted lower eyelids, which usually result from ...
(Date:1/16/2017)... Annapolis, Maryland (PRWEB) , ... January 16, 2017 ... ... Kevin Thibodeau has been appointed Chief Executive Officer of the medical device company, ... said Vixiar Chairman Robert Storey. “Kevin has a strong track record in ...
(Date:1/15/2017)... ... , ... Whole Health Supply, LLC is announcing the release of an updated version of their ... , The 2017 edition has wide jaws that will accommodate nails up to 4mm ... as diabetics. This handle is reinforced for extra strength when pressing down on dense nails ...
(Date:1/15/2017)... (PRWEB) , ... January 14, 2017 , ... Wondering where ... Gram Dinner delivered straight to your door for a romantic, lobster feast in the ... in time for Valentine's Day. The dinners will be featured until February 15th, ...
(Date:1/14/2017)... ... 13, 2017 , ... According to a December 9 ... lower the risk of type 2 diabetes, Alzheimer’s, and cardiovascular disease. Southern California ... benefits linked to a Mediterranean diet are only some of the many reasons ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... BRIDGEWATER, N.J. , Jan. 16, 2017   Linde ... substantially all of the assets and business of The Service ... respiratory equipment repair services to healthcare providers in the Midwest ... in Broadview, Illinois , The Service Center ... and Greenville, South Carolina . Its primary ...
(Date:1/16/2017)... Jan. 16, 2017  Dovetail Genomics today announced the ... assembly service, which yields chromosome-scale genome assemblies. The service ... Dovetail-hosted workshop on Jan. 17 at the Plant & ... Diego . "We are thrilled to ... of our Dovetail Hi-C offering," said Todd Dickinson ...
(Date:1/16/2017)... Calif. , Jan. 16, 2017  Rigel Pharmaceuticals ... January 3, 2017 and January 16, 2017 the Compensation ... of inducement stock options to purchase an aggregate of ... These awards were granted pursuant to the Rigel Pharmaceuticals, ... to the new employees entering into employment with Rigel, ...
Breaking Medicine Technology: